Dual effect of lobeline on α4β2 rat neuronal nicotinic receptors

European Journal of Pharmacology

Volumn 658, Issue 2-3, 2011, Pages 108-113

  Kaniaková, Martina ^a   Lindovský, Jiří ^a   Krůšek, Jan ^a   Adámek, Svatopluk ^b   Vyskočil, František ^a,b  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

4 2; Lobeline; Nicotinic acetylcholine receptor

Indexed keywords

ACETYLCHOLINE; LOBELINE; NICOTINIC RECEPTOR ALPHA4BETA2; RECEPTOR SUBUNIT; TUBOCURARINE CHLORIDE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; DRUG STRUCTURE; GENETIC TRANSFECTION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; SENSITIVITY ANALYSIS;

ACETYLCHOLINE; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DRUG SYNERGISM; LOBELINE; NEURONS; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RATS; RECEPTORS, NICOTINIC;

EID: 79953781181     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.02.012     Document Type: Article

References (33)

1. Akk, G., Milescu, L.S., Heckmann, M., 2005. Activation of heteroliganded mouse muscle nicotinic receptors. J. Physiol. 564, 359-376. (Pubitemid 40585039)
2. Arias, H.R., 1998. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Biochim. Biophys. Acta 1376, 173-220.
3. Arias, H.R., 2000. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors. Neurochem. Int. 36, 595-645.
4. Beranek, R., Vyskocil, F., 1968. The effect of atropine on the frog sartorius neuromuscular junction. J. Physiol. 195, 493-503.
5. Briggs, C.A., McKenna, D.G., 1998. Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists. Neuropharmacology 37, 1095-1102. (Pubitemid 29027823)
6. Cohen, J.B., Strnad, N.P., 1987. Permeability Control and Desensitization by Nicotinic Acetylcholine Receptor. In: Konjin, T.M., Van de Starre, H., Van der Wel, H., Houslay, M.D. (Eds.), Molecular Mechanisms of Desensitization to Signal Molecules. Berlin & Heidelberg, Springer-Verlag, pp. 257-273.
7. Colquhoun, D., 1998. Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br. J. Pharmacol. 125, 924-947.
8. Cooper, J.C., Gutbrod, O., Witzemann, V., Methfessel, C., 1996. Pharmacology of the nicotinic acetylcholine receptor from fetal rat muscle expressed in Xenopus oocytes. Eur. J. Pharmacol. 309, 287-298.
9. Covernton, P.J., Kojima, H., Sivilotti, L.G., Gibb, A.J., Colquhoun, D., 1994. Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in Xenopus oocytes. J. Physiol. 481 (Pt 1), 27-34. (Pubitemid 24361345)
10. Damaj, M.I., Patrick, G.S., Creasy, K.R., Martin, B.R., 1997. Pharmacology of lobeline, a nicotinic receptor ligand. J. Pharmacol. Exp. Ther. 282, 410-419.
11. Decker, M.W., Majchrzak, M.J., Arneric, S.P., 1993. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol. Biochem. Behav. 45, 571-576.
12. Dittert, I., Vlachova, V., Knotkova, H., Vitaskova, Z., Vyklicky, L., Kress, M., Reeh, P.W., 1998. A technique for fast application of heated solutions of different composition to cultured neurones. J. Neurosci. Meth. 82, 195-201.
13. Dwoskin, L.P., Crooks, P.A., 2002. A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. Biochem. Pharmacol. 63, 89-98.
14. Felpin, F.X., Lebreton, J., 2004. History, chemistry and biology of alkaloids from Lobelia inflata. Tetrahedron 60, 10127-10153. (Pubitemid 39303964)
15. Gerzanich, V., Peng, X., Wang, F., Wells, G., Anand, R., Fletcher, S., Lindstrom, J., 1995. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48, 774-782.
16. Giniatullin, R., Nistri, A., Yakel, J.L., 2005. Desensitization of nicotinic ACh receptors: shaping cholinergic signaling. Trends Neurosci. 28, 371-378. (Pubitemid 40853860)
17. Glennon, R.A., Dukat, M., 2000. Central nicotinic receptor ligands and pharmacophores. Pharm. Acta Helv. 74, 103-114.
18. Hansen, S.B., Sulzenbacher, G., Huxford, T., Marchot, P., Taylor, P., Bourne, Y., 2005. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J. 24, 3635-3646. (Pubitemid 41509370)
19. Karadsheh, M.S., Shah, M.S., Tang, X., Macdonald, R.L., Stitzel, J.A., 2004. Functional characterization of mouse alpha4beta2 nicotinic acetylcholine receptors stably expressed in HEK293T cells. J. Neurochem. 91, 1138-1150. (Pubitemid 39587452)
20. Kenakin, T., 2006. Orthosteric Drug Antagonism. A Pharmacology Primer. Elsevier, pp. 99-126.
21. Krůšek, J., Vyskočil, F., 2003. Different degree of cooperativity in adult, embryonic and mutated mouse muscle nicotinic receptors. Biochim. Biophys. Acta 1646, 119-130.
22. Maelicke, A., Albuquerque, E.X., 2000. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease. Eur. J. Pharmacol. 393, 165-170.
23. Mayer, M.L., Vyklicky Jr., L., Clements, J., 1989. Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature 338, 425-427. (Pubitemid 19089323)
24. Moroni, M., Bermudez, I., 2006. Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types. J. Mol. Neurosci. 30, 95-96.
25. Parker, M.J., Beck, A., Luetje, C.W., 1998. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity. Mol. Pharmacol. 54, 1132-1139.
26. Smulders, C.J., Van Kleef, R.G., de Groot, A., Gotti, C., Vijverberg, H.P., 2004. A noncompetitive, sequential mechanism for inhibition of rat alpha4beta2 neuronal nicotinic acetylcholine receptors by carbamate pesticides. Toxicol. Sci. 82, 219-227.
27. Smulders, C.J., Zwart, R., Bermudez, I., van Kleef, R.G., Groot-Kormelink, P.J., Vijverberg, H.P., 2005. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism. Eur. J. Pharmacol. 509, 97-108.
28. Strecker, G.J., Jackson, M.B., 1989. Curare binding and the curare-induced subconductance state of the acetylcholine receptor channel. Biophys. J. 56, 795-806. (Pubitemid 19242212)
29. Terry Jr., A.V., Williamson, R., Gattu, M., Beach, J.W., McCurdy, C.R., Sparks, J.A., Pauly, J.R., 1998. Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine. Neuropharmacology 37, 93-102. (Pubitemid 28300141)
30. Wu, J., Liu, Q., Yu, K., Hu, J., Kuo, Y.P., Segerberg, M., St John, P.A., Lukas, R.J., 2006. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4- containing nicotinic receptors. J. Physiol. 576, 103-118. (Pubitemid 44426224)
31. Zwart, R., van Kleef, R.G., Gotti, C., Smulders, C.J., Vijverberg, H.P., 2000. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase- inhibiting drugs. J. Neurochem. 75, 2492-2500.
32. Zwart, R., Vijverberg, H.P., 1997. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects. Mol. Pharmacol. 52, 886-895.
33. Zwart, R., Vijverberg, H.P., 2000. Potentiation and inhibition of neuronal alpha4beta4 nicotinic acetylcholine receptors by choline. Eur. J. Pharmacol. 393, 209-214.